CV Lattes
ORCID
Google Scholar Citations
Universidade Nove de Julho (UNINOVE). Campus Vergueiro (Institutional affiliation from the last research proposal) Birthplace: Brazil
I have a degree in Biology, a master's degree in Medicine (Nephrology) from the Federal University of São Paulo (2002), a doctorate in Health Sciences/Nephrology from the Federal University of São Paulo (2006) and a post-doctorate in Health Sciences/Nephrology) from Federal University of São Paulo (2011). Professor of the Undergraduate Course in Medicine, in the curricular subject Morphofunctional Bases/Nephrology, internship professor in the laboratory for Biomedicine undergraduate students, professor in the Courses: Lato Sensu Exercise Physiology, Cardiorespiratory Physiology and in the Postgraduate Courses in Medicine - Progress in Pathophysiology and Treatment of Chronic Kidney Disease and in the Postgraduate Course in Biophotonics (CAPES 6) - Experimental Models and professor and researcher in the Postgraduate Department of Medicine at Universidade Nove de Julho (CAPES 5). President of the Ethics Committee of Universidade Nove de Julho (2020 - 2023). Has experience in pathophysiological mechanisms in the area of #8203;#8203;Medicine - Health Sciences, with an emphasis on kidney disease and comorbidities (Inflammation, uremic toxins, hypertension, diabetes, bone mineral disease, cardiovascular disease, anemia, obesity, sarcopenia and COVID-19) (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
In the period from December 2019 to January 2022, approximately 400 million cases of COVID-19, caused by the SARS-COV2 virus, were confirmed worldwide with approximately 6,000,000 deaths. COVID-19 manifests with systemic disorders, particularly severe pneumonia and respiratory syndrome. In addition to respiratory complications, acute kidney injury (AKI) was a major complication of COVID-1…
The prevalence of chronic kidney disease (CKD) ranges from 1.7% to 8.1%, with an estimated prevalence of 5.6% in the general population, and it has a major impact on public health in the elderly, affecting up to 11% of the population. Hemodialysis (HD) is a technique usually performed by about 90% of patients. However, this has adverse effects such as: large fluctuations in weight, osmola…
In addition to the vitamin D being associated with the metabolism of calcium and phosphorus, it has been described that vitamin D is also involved in the modulation of cell mechanisms of innate immunity. The discovery that the vitamin D receptor (VDR) and 1±-hydroxylase enzyme (CYP27B1) are present in cells of the immune system has revolutionized the field of immunology associated with vi…
Bacterial infections are the first cause of hospitalization and second cause of mortality in chronic kidney diseases (CKD) patients, suggesting an immunodeficiency in this population to eliminate pathogens. It has been described an important association between a depressed immunologic response in CKD patients and presence of uremic toxins. The uremic toxins has been reported to reduce rea…
Cardiovascular (CV) and infectious diseases remain the most common causes of mortality and morbidity, respectively among patients with chronic kidney disease (CKD). Previous studies have reported several alterations in immune cells, which contribute to increase incidence of CV and infectious diseases observed in this population. Biocompatibility of dialysis membrane and uremic toxins are …
| 1 / 1 | Ongoing grants |
| 4 / 3 | Completed research grants |
| 2 / 1 | Completed scholarships in Brazil |
| 7 / 5 | All research grants and scholarships |
| Associated processes | |